2 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Antigens, Differentiation: new trials by email Literature Review of Antigens, Differentiation trials Research Report on Antigens, Differentiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma Anti-NY ESO-1 T cell receptor (TCR) cluster of differentiation 62L (CD62L)+ cells, Aldesleukin, Cyclophosphamide - Metastatic Cancer, Metastatic Melanoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2014-02-01 | 2016-06-24 |
| The Effects of Antibiotic Combinations on Stem Cells Differentiation Markers - Stem Cells, Anti-Bacterial Agents | Completed | Eskisehir Osmangazi University | 3 | 2014-01-01 | 2021-01-19 | |
| Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells - Scleroderma, Cardiac Involvement | Phase 2 | Completed | University Hospital Tuebingen | 44 | 2012-09-01 | 2024-07-29 |
Melanoma (1) · Neoplasm Metastasis (1) · Scleroderma, Diffuse (1)
Eskisehir Osmangazi University (1) · National Cancer Institute (NCI) (1) · University Hospital Tuebingen (1)
Germany (1) · Turkey (Türkiye) (1) · United States (1)
Joerg C Henes, MD (1) · Steven A Rosenberg, M.D. (1)